Moderna reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Moderna using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $0.03 | $-1.90 | 101.6 % |
Jun 2024 | 2024-08-01 | $-3.33 | $-3.39 | 1.77 % |
Mar 2024 | 2024-05-02 | $-3.07 | $-3.35 | 8.36 % |
Dec 2023 | 2024-02-22 | $0.55 | $-0.97 | 156.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $1.86B | $1.25B | 49.0 % |
Jun 2024 | 2024-08-01 | $241.00M | $132.18M | 82.3 % |
Mar 2024 | 2024-05-02 | $167.00M | $90.99M | 83.5 % |
Dec 2023 | 2024-02-22 | $2.81B | $2.49B | 12.9 % |
Moderna (MRNA) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $0.03, which beat the estimate of $-1.90.
The Actual Revenue was $1.9B, which beat the estimate of $1.3B.
Browse earnings estimates, EPS, and revenue on all stocks.